RxSight, Inc. RXST
5.40 USD +0.12 (+2.18%)
Nov 12, 2026, 3:15 PM EST
5.04 Day range 5.49
4.11 52-week range 13.22
- YTD
- -48.22%
- 1 year
- -46.10%
News
benzinga.com Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $8 Piper Sandler analyst Adam Maeder maintains RxSight (NASDAQ:RXST) with a Neutral and lowers the price target from $10 to $8.
benzinga.com Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $6 Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lowers the price target from $9 to $6.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…
benzinga.com Needham Maintains Buy on RxSight, Lowers Price Target to $7 Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $11 to $7.
benzinga.com RxSight Q3 2026 Earnings Call Transcript RxSight (NASDAQ:RXST) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com RxSight Q3 Adj. EPS $(0.21) Beats $(0.29) Estimate, Sales $24.586M Miss $27.137M Estimate RxSight (NASDAQ:RXST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 425 percent decrease over losses of $(0.04) per…- benzinga.com B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $5.5 B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $6.5 to $5.5.
benzinga.com Stifel Maintains Hold on RxSight, Lowers Price Target to $7 Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $8 to $7.- benzinga.com UBS Maintains Neutral on RxSight, Raises Price Target to $6.3 UBS analyst Patrick Wood maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price target from $5.5 to $6.3.
- benzinga.com RxSight Appoints Aziz Mottiwala President, CEO, Effective July 20, Succeeding Ron Kurtz RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D.,…
benzinga.com B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $6.5 B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $8 to $6.5.
benzinga.com Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED) U.S. stock futures were mixed on Tuesday, as the Dow Jones index rose while the Nasdaq 100 and S&P 500 indices fell.
benzinga.com Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday US stock futures trade lower, investors focus on PENG, RXST, SAR earnings, RIVN's public offering, and EPAC's expected earnings. Check premarket coverage.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-market session. Crinetics Pharmaceuticals (NASDAQ:CRNX) stock moved upwards by 99.85% to $84.0. The…- benzinga.com RxSight Raises FY2026 Sales Guidance from $120.000M-$135.000M to $140.000M-$160.000M vs $129.250M Est RxSight (NASDAQ:RXST) raises FY2026 sales outlook from $120.000 million-$135.000 million to $140.000 million-$160.000 million vs $129.250 million estimate.
benzinga.com RxSight Sees Q2 Revenue Of $32M-$34M; Sees FY2026 Revenue Of $140M-$160M RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the…- benzinga.com Alcon And RxSight Announce A Non-Exclusive Collaboration To Jointly Develop Adjustable Presbyopia-Correcting Intraocular Lenses Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality…
benzinga.com Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $9 Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lowers the price target from $11 to $9.
benzinga.com Needham Maintains Buy on RxSight, Lowers Price Target to $11 Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $13 to $11.
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com RxSight Affirms FY2026 Sales Guidance of $120.000M-$135.000M vs $129.182M Est 2026 Guidance: The company's 2026 financial guidance is as follows:Revenue of $120 to $135 million, in-line with previous guidanceGross margin of 70% to 72%, in-line with previous guidanceOperating…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Earnings Scheduled For February 25, 2026
benzinga.com Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday 
benzinga.com Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Earnings Scheduled For August 7, 2025 - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Earnings Scheduled For May 7, 2025
- benzinga.com 11 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall 
benzinga.com RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For February 25, 2025
- benzinga.com Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
- benzinga.com Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- benzinga.com Earnings Scheduled For February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
- benzinga.com Earnings Scheduled For November 9, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
- benzinga.com Earnings Scheduled For August 7, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.
- benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
- benzinga.com Earnings Scheduled For March 6, 2023 Companies Reporting Before The Bell • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 7, 2022 Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
- benzinga.com Earnings Scheduled For August 8, 2022 Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For May 5, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.